Both in Biotechnology
Surrozen vs Fennec Pharmaceuticals
Over the past year SRZN returned +174.3% and FENC returned +18.8%; their daily moves had a correlation of 0.13.
SRZN +174.3% FENC +18.8%Growth of $1, one year, split-adjusted
| Metric | SRZN | FENC |
|---|---|---|
| Price | $31.98 | $10.80 |
| Market cap | $375.9M | $378.7M |
| Today | +7.89% | −1.37% |
| 1 month | +42.6% | −12.0% |
| 6 months | +16.5% | +87.2% |
| Year to date | +41.5% | +40.3% |
| 1 year | +176.6% | +19.5% |
| Revenue growth (YoY) | +408.6% | +85.2% |
| Gross margin | 100.0% | 96.0% |
| Net margin | 640.8% | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | 32.7× | 6.4× |
| Net cash | $102.0M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 166.5% | 58.5% |
| Short % of float | 53.5% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).